Integrated Report

Overview

The report presents Mochida Pharmaceutical Group's integrated financial and ESG activities for FY2020, covering April 1, 2020 to March 31, 2021. It highlights environmental performance, including FY2020 energy consumption of 354 terajoules, CO2 emissions of 17,005 t-CO2, and waste generation of 463 t, alongside targets for FY2030. The company reports achieving a 9.9% female-manager ratio and continuing initiatives on diverse workstyles, workplace safety and employee support. It also describes the President-led COVID-19 Task Force, remote-work measures and efforts to maintain pharmaceutical supply.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2020
Period: 1 April 2020 – 31 March 2021
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services